Top Markets
#1 Cortex Cortex +32.54%
#2 龙虾 (Lobster) 龙虾 (Lobster) +30.50%
#3 Akedo Akedo +24.47%
#4 DexNet DexNet +23.20%
#5 wojak wojak +16.38%
#6 Pons Pons +15.15%
#7 APEX APEX +13.93%
#8 OpenEden OpenEden +13.52%
#9 The Black Bull The Black Bull +9.93%
#10 Official Trump Official Trump +9.41%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rank in Stocks #7323
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Share Price
$36.75
Last synced: 2026-08-27
Market Cap
$1.63B
Change (1 day)
-0.78%
Change (1 year)
-
Country
US
Trade Avalyn Pharma Inc. Common Stock (AVLN)

Category

Healthcare
Earnings for Avalyn Pharma Inc. Common Stock (AVLN)
Earnings in 2026 TTM: 0
According to Avalyn Pharma Inc. Common Stock latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Avalyn Pharma Inc. Common Stock from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH